CABR Caring Brands, Inc.
Perfumes, Cosmetics & Other Toilet Preparations · Nasdaq · SEC CIK 2020737 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-140.5%
TTM EPS YoY-229.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-142.4%
ROA-129.0%
ROIC (approx.)-377.0%
Asset turnover—
Leverage & solvency
Liabilities / assets6.1%
Debt / equity0.00x
Current ratio16.32x
Interest coverage-23.73x
Cash quality & payout
Operating cash flow / net income0.43x
Accruals ratio-72.9%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q42024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | — | — | — | $420 | $740 | $1,587 | $1,469 | $465 |
| Cost of revenue | — | — | — | $181 | $292 | $722 | $678 | $2,072 |
| Gross profit | — | — | — | $239 | $448 | $865 | $791 | -$1,607 |
| R&D expense | — | — | — | $0 | — | — | — | $0 |
| SG&A expense | $93,773 | $26,187 | $88,536 | $85,315 | $10,890 | $21,331 | $30,159 | $26,462 |
| Operating income | -$701,166 | -$638,737 | -$1.72M | -$3.74M | -$999,475 | -$659,583 | -$539,343 | -$872,821 |
| Interest expense | $23 | $39 | $286,989 | -$554 | $19,293 | $0 | $427 | -$10,030 |
| Income tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — |
| Net income | -$700,978 | -$638,726 | -$2.01M | -$4.06M | -$1.02M | -$660,583 | -$538,770 | -$862,791 |
| EBITDA | — | — | — | -$3.66M | -$924,475 | -$584,583 | -$464,343 | -$722,821 |
| EPS (basic) | -0.08 | -0.10 | -0.27 | — | -0.08 | -0.05 | -0.04 | -0.07 |
| EPS (diluted) | -0.08 | -0.10 | -0.27 | — | -0.08 | -0.05 | -0.04 | -0.07 |
| Weighted avg. shares (diluted) | 10.13M | 8.99M | 14.45M | — | 13.44M | 13.34M | 13.22M | 13.09M |
| Banking | ||||||||
| Net interest income | $23 | $39 | $286,989 | -$554 | $19,293 | $0 | $427 | -$10,030 |
| Balance sheet | ||||||||
| Cash & equivalents | $7.67M | $1.82M | $2.03M | $2.19M | $16,123 | — | — | $468,998 |
| Inventory | $12,807 | $12,807 | $12,807 | $12,807 | $12,892 | — | — | $13,689 |
| Current assets | $8.31M | $1.91M | $2.17M | $2.33M | $45,991 | — | — | $527,481 |
| Intangibles | $0 | $0 | $0 | $2.55M | $2.62M | — | — | $2.85M |
| Total assets | $8.31M | $1.91M | $2.17M | $2.33M | $3.17M | — | — | $3.88M |
| Current liabilities | $509,519 | $384,646 | $384,473 | $176,844 | $570,210 | — | — | $186,105 |
| Short-term debt | — | — | — | — | $129,405 | — | — | — |
| Long-term debt | — | — | — | $58,650 | $1,863 | — | — | — |
| Total debt | — | — | — | $58,650 | $131,268 | — | — | — |
| Total liabilities | $509,519 | $384,646 | $384,473 | $235,494 | $572,073 | — | — | $186,105 |
| Shareholders' equity | $7.80M | -$2.71M | -$2.00M | $2.09M | $2.60M | $3.11M | $3.38M | $3.69M |
| Net debt | — | — | — | -$2.13M | $115,145 | — | — | — |
| Shares outstanding | 10.47M | 9.09M | 8.84M | 14.76M | 13.74M | — | — | 13.11M |
| Cash flow statement | ||||||||
| Operating cash flow | -$1.15M | -$463,073 | -$550,794 | -$1.06M | -$180,770 | -$209,331 | -$241,774 | -$272,248 |
| Investing cash flow | — | — | — | — | — | — | — | $608,596 |
| Financing cash flow | $6.99M | $250,000 | $395,000 | $3.23M | $123,000 | — | — | — |
| Depreciation & amortization | — | — | — | $75,000 | $75,000 | $75,000 | $75,000 | $150,000 |
| Stock-based compensation | $110,581 | $67,467 | $969,029 | — | — | — | — | $400,000 |
| Dividends paid | $84,654 | — | — | — | — | — | — | — |
| Share buybacks | $150,000 | $0 | $3.08M | — | — | — | — | — |
Free plan shows the latest 8 periods; Pro shows all 9 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.